Eric Fluhler

1.4k total citations
21 papers, 918 citations indexed

About

Eric Fluhler is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Eric Fluhler has authored 21 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Pharmacology. Recurrent topics in Eric Fluhler's work include Biosimilars and Bioanalytical Methods (8 papers), Advanced Biosensing Techniques and Applications (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Eric Fluhler is often cited by papers focused on Biosimilars and Bioanalytical Methods (8 papers), Advanced Biosensing Techniques and Applications (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Eric Fluhler collaborates with scholars based in United States, Switzerland and United Kingdom. Eric Fluhler's co-authors include Leslie M. Loew, Mauricio Leal, Stephen L. Yates, Azher Hussain, Michael Mayersohn, Patrick M. Lippiello, Daniel L. Farkas, Benjamin Ehrenberg, P M Lippiello and Boris Gorovits and has published in prestigious journals such as Biochemistry, Biophysical Journal and Annals of Oncology.

In The Last Decade

Eric Fluhler

21 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Fluhler United States 14 407 261 96 95 84 21 918
Alexander Alanine Switzerland 16 753 1.9× 143 0.5× 158 1.6× 121 1.3× 66 0.8× 26 1.3k
Mark Namchuk United States 17 1.0k 2.5× 135 0.5× 67 0.7× 108 1.1× 35 0.4× 29 1.7k
Xiangbing Qi China 28 1.2k 3.0× 90 0.3× 88 0.9× 121 1.3× 108 1.3× 74 2.9k
Huanhuan Wang China 16 487 1.2× 130 0.5× 61 0.6× 149 1.6× 27 0.3× 73 1.3k
Eric S. Dawson United States 21 659 1.6× 302 1.2× 23 0.2× 92 1.0× 43 0.5× 42 1.1k
Constanţa Ganea Romania 21 534 1.3× 239 0.9× 68 0.7× 53 0.6× 22 0.3× 51 956
Stéphane Marchal France 22 879 2.2× 164 0.6× 51 0.5× 98 1.0× 22 0.3× 55 1.6k
Wade D. Van Horn United States 24 1.2k 2.9× 221 0.8× 71 0.7× 51 0.5× 27 0.3× 41 1.8k
Simone Sciabola United States 21 1.1k 2.7× 132 0.5× 50 0.5× 127 1.3× 75 0.9× 36 1.6k
Yiran Wu China 23 1.0k 2.5× 381 1.5× 42 0.4× 171 1.8× 58 0.7× 74 1.7k

Countries citing papers authored by Eric Fluhler

Since Specialization
Citations

This map shows the geographic impact of Eric Fluhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Fluhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Fluhler more than expected).

Fields of papers citing papers by Eric Fluhler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Fluhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Fluhler. The network helps show where Eric Fluhler may publish in the future.

Co-authorship network of co-authors of Eric Fluhler

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Fluhler. A scholar is included among the top collaborators of Eric Fluhler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Fluhler. Eric Fluhler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Booth, Brian, Faye Vazvaei, Eric Fluhler, Heather Myler, & Eric Woolf. (2019). AAPS Workshop Report on ICH M10. The AAPS Journal. 22(1). 10–10. 5 indexed citations
2.
Fluhler, Eric, et al.. (2018). Report on the 18th Annual Land O'Lakes Bioanalytical Conference. Bioanalysis. 10(7). 445–449. 1 indexed citations
3.
Raje, Sangeeta, Ernesto Callegari, Vaishali Sahasrabudhe, et al.. (2018). Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin. Clinical and Translational Science. 11(4). 405–411. 33 indexed citations
4.
Gudi, Girish, et al.. (2018). Preliminary pharmacokinetic results from a phase I study of GBR 1302 in patients with HER2 positive cancers. Annals of Oncology. 29. x34–x34. 1 indexed citations
5.
Fluhler, Eric, et al.. (2015). 16th Annual Land O’Lakes Bioanalytical Conference. Bioanalysis. 7(21). 2731–2734. 2 indexed citations
6.
Booth, Brian, Mark E. Arnold, Binodh DeSilva, et al.. (2014). Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance. The AAPS Journal. 17(2). 277–288. 86 indexed citations
7.
Fluhler, Eric, Faye Vazvaei, Puran Singhal, et al.. (2014). Repeat Analysis and Incurred Sample Reanalysis: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. The AAPS Journal. 16(6). 1167–1174. 34 indexed citations
8.
Fluhler, Eric, et al.. (2014). Summary of The 2014 Land O’Lakes Bioanalytical Conference. Bioanalysis. 6(21). 2915–2918. 1 indexed citations
9.
Hussain, Azher, Boris Gorovits, Mauricio Leal, & Eric Fluhler. (2013). PK of Immunoconjugate Anticancer Agent Cmd-193 in Rats: Ligand-Binding Assay Approach to DetermineIn VivoImmunoconjugate Stability. Bioanalysis. 6(1). 21–32. 9 indexed citations
10.
Ji, Qin, et al.. (2012). Conference Report: Emerging Technology For Bioanalysis in The Next Decade. Bioanalysis. 4(21). 2557–2561. 1 indexed citations
11.
Ji, Allena, et al.. (2009). Determination of Tigecycline in Human Skin Using a Novel Validated LC–MS/MS Method. Bioanalysis. 2(1). 81–94. 16 indexed citations
12.
Ji, Allena, et al.. (2008). A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 48(3). 866–875. 38 indexed citations
13.
Hussain, Azher, et al.. (2007). Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species. Drug Metabolism and Disposition. 35(10). 1886–1893. 109 indexed citations
14.
Ji, Allena, et al.. (2007). A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat bone. Journal of Pharmaceutical and Biomedical Analysis. 44(4). 970–979. 25 indexed citations
15.
DiJoseph, John F., et al.. (1996). THERAPEUTIC BLOOD LEVELS OF SIROLIMUS (RAPAMYCIN) IN THE ALLOGRAFTED RAT. Transplantation. 62(8). 1109–1112. 33 indexed citations
16.
Yates, Stephen L., et al.. (1995). Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or α4β2 receptors to nicotine. Biochemical Pharmacology. 50(12). 2001–2008. 57 indexed citations
17.
Yates, Stephen L., Eric Fluhler, & P M Lippiello. (1992). Advances in the use of the fluorescent probe fura‐2 for the estimation of intrasynatposomal calcium. Journal of Neuroscience Research. 32(2). 255–260. 29 indexed citations
18.
Fluhler, Eric, John K. Hurley, & Irene E. Kochevar. (1989). Laser intensity and wavelength dependence of Rose-Bengal-photosensitized inhibition of red blood cell acetylcholinesterase. Biochimica et Biophysica Acta (BBA) - General Subjects. 990(3). 269–275. 23 indexed citations
19.
Ehrenberg, Benjamin, et al.. (1987). Membrane potential induced by external electric field pulses can be followed with a potentiometric dye. Biophysical Journal. 51(5). 833–837. 68 indexed citations
20.
Fluhler, Eric, et al.. (1985). Spectra, membrane binding, and potentiometric responses of new charge shift probes. Biochemistry. 24(21). 5749–5755. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026